Literature DB >> 27743476

In Reply.

Klaus G Parhofer.   

Abstract

Year:  2016        PMID： 27743476      PMCID： PMC5078870          DOI： 10.3238/arztebl.2016.0643c

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  5 in total

1.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

Review 2.  2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.

Authors:  Donald M Lloyd-Jones; Pamela B Morris; Christie M Ballantyne; Kim K Birtcher; David D Daly; Sondra M DePalma; Margo B Minissian; Carl E Orringer; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2016-04-01       Impact factor: 24.094

Review 3.  The Treatment of Disorders of Lipid Metabolism.

Authors:  Klaus G Parhofer
Journal:  Dtsch Arztebl Int       Date:  2016-04-15       Impact factor: 5.594

4.  The 2015 Dietary Guidelines Advisory Committee Report Concerning Dietary Cholesterol.

Authors:  Kim A Williams; Amanda J Krause; Sarah Shearer; Stephen Devries
Journal:  Am J Cardiol       Date:  2015-08-14       Impact factor: 2.778

5.  Effectiveness of two statin prescribing strategies with respect to adherence and cardiovascular outcomes: observational study.

Authors:  L Wei; T M MacDonald; A D Watson; M J Murphy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-04       Impact factor: 2.890
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.